Translating research to diagnosis, therapy, and patient care"
KILM PhD call 2021
The Department of Laboratory Medicine (KILM) at the Medical University Vienna is launching a call for prospective PhD students, who are interested in cutting-edge research in the field of molecular-translational medicine.
The KILM Group Leaders focus on the unmet clinical needs in the fields of immunotherapy and immunomodulation of cardiovascular diseases, metabolic disorders, and cancer.
Scientific topics for this call :
1. Immunotherapy of hematological malignancies
PI : Robert Kralovics; ORCID : 0000-0002-6997-8539)
2. Immunotherapy of cardiovascular diseases and lipid disorders
PI : Dimitrios Tsiantoulas; ORCID : 0000-0002-7743-3192)
3. Peptide therapeutics for fatty liver disease
PI : Tim Hendrikx; ORCID : 0000-0002-3381-2107)
4. Immunotherapy of atherothrombosis
PI : Christoph Binder; ORCID : 0000-0001-8313-7050)
5. Immune-metabolism in liver disease
PIs : Erwin Wagner; ORCID : 0000-0001-7872-0196 & Latifa Bakiri; ORCID : 0000-0002-6300-2420)
Successful candidates should hold a Master / Diploma degree in Biology, Medicine, Molecular Biology, Biotechnology, Biomedicine or a related subject.
Applicants are expected to be highly motivated, proactive, self-organized and reliable. Excellent oral as well as written communication skills (English min. level C1) are needed.
We offer :
The successful applicants will have fully funded positions for up to 4 years and will be integrated into the PhD curriculum of the Medical University of Vienna.
The Medical University of Vienna is one of the largest research organizations in Austria and one of the major medical research institutions in Europe.
The KILM PIs are committed to provide in-depth training, a highly motivating and interactive environment and access to state-of-the-art technologies.